Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Psychol Res Behav Manag ; 17: 1045-1055, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38495086

RESUMEN

Background: Promoting participation and autonomy (PA) in society has been highlighted as an ultimate goal of rehabilitation for people with chronic diseases by the World Health Organization, but few studies have focused on PA in people with Parkinson's disease (PD). Therefore, this study aimed to determine the level of PA in PD patients and investigate the associated psychological and behavioural factors. Methods: PD patients were recruited from the Department of Neurology of the First Hospital Affiliated with Dalian Medical University using convenience sampling for this cross-sectional study. A questionnaire covering social-demographic and disease-related characteristics, Chinese version of Impact on Participation and Autonomy (IPA) Questionnaire, Connor-Davidson Resilience Scale (CD-RISC), Self-rating Depression Scale (SDS), Self-rating Anxiety Scale (SAS), Medical Coping Modes Questionnaire (MCMQ), Social Support Rating Scale (SSRS), Hoehn-Yahr Staging System and Unified Parkinson's Disease Rating Scale (UPDRS) were used for investigation. A multivariate stepwise linear regression analysis was used to determine the factors that influence IPA. Results: A total of 326 PD patients responded to all the questionnaires. The patients had a mean IPA score of 46.6 (SD 21.79). Multiple linear regression analyses revealed that UPDRS II (ß = 0.35, p < 0.001) had the strongest correlation with IPA, followed by tenacity, which was the second strongest factor (ß = -0.25, p < 0.001). Hoehn-Yahr stage (ß = 0.19, p < 0.001) and availability of social support (ß =-0.12, p =0.001) were also strong factors. Conclusion: The average level of PA among PD patients was at the lower middle-level. Among PD patients, physical function, psychological resilience and social support were the strongest factors associated with PA. These findings provide valuable insights into PD patients' PA and can help medical professionals identify the early risks of restricted PA among PD patients, implement interventions to promote PA and ultimately achieve rehabilitation.

2.
FEMS Microbiol Lett ; 3702023 01 17.
Artículo en Inglés | MEDLINE | ID: mdl-37960899

RESUMEN

Probiotics have been demonstrated to lower total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) in individuals with mild hypercholesterolemia. Our previous study found that intervention with Bacillus subtilis R-179 and Enterococcus faecium R-026, well-known probiotics, improved obesity-associated dyslipidemia through ameliorating the gut microbiota, but similar studies on hypercholesterolemia have not been reported to date. Here, we investigated the therapeutic effect of live combined B. subtilis R-179 and E. faecium R-026 (LCBE) in a C57BL/6 mouse model of hypercholesterolemia. A total of 40 mice were administered with a high-cholesterol diet (containing 1.2% cholesterol) to establish a state of hypercholesterolemia for 4 weeks. Then, mice were divided into one model group (group M) and three treatment groups (n = 10 per group), which were administered with LCBE at 0.023 g/mouse/day (group L) or 0.230 g/mouse/day (group H), or atorvastatin 0.010 g/kg/day (group A), for 5 weeks while on a high-cholesterol diet. LCBE at high doses significantly alleviated the symptoms of group M and reduced serum TC, LDL-C, and lipopolysaccharide (LPS). LCBE improved liver steatosis and adipocyte enlargement caused by a high-cholesterol diet. In addition, the administration of LCBE regulated the change in gut microbiota and diversity (Shannon index). Compared with group M, the relative abundance of Actinobacteriota, Colidextribacter, and Dubosiella dramatically decreased in the treatment groups, which were positively correlated with serum TC and LPS. These findings indicated that the mechanism of action of LCBE in treating hypercholesterolemia may be modulation of the gut microbiota. In conclusion, LCBE ameliorated lipid accumulation, reduced inflammation, and alleviated the gut microbiota imbalance in hypercholesterolemic mice. These findings support the probiotic role of LCBE as a clinical candidate for the treatment of hypercholesterolemia.


Asunto(s)
Enterococcus faecium , Microbioma Gastrointestinal , Hipercolesterolemia , Probióticos , Ratones , Animales , Bacillus subtilis , LDL-Colesterol/farmacología , LDL-Colesterol/uso terapéutico , Lipopolisacáridos/farmacología , Ratones Endogámicos C57BL , Colesterol , Probióticos/farmacología
3.
Front Plant Sci ; 14: 1101828, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36818859

RESUMEN

Introduction: Current aerial plant protection with Unmanned Aerial Vehicles (UAV) usually applies full coverage route planning, which is challenging for plant protection operations in the orchards in South China. Because the fruit planting has the characteristics of dispersal and irregularity, full-coverage route spraying causes re-application as well as missed application, resulting in environmental pollution. Therefore, it is of great significance to plan an efficient, low-consumption and accurate plant protection route considering the flight characteristics of UAVs and orchard planting characteristics. Methods: This study proposes a plant protection route planning algorithm to solve the waypoint planning problem of UAV multi-objective tasks in orchard scenes. By improving the heuristic function in Ant Colony Optimization (ACO), the algorithm combines corner cost and distance cost for multi-objective node optimization. At the same time, a sorting optimization mechanism was introduced to speed up the iteration speed of the algorithm and avoid the influence of inferior paths on the optimal results. Finally, Multi-source Ant Colony Optimization (MS-ACO) was proposed after cleaning the nodes of the solution path. Results: The simulation results of the three test fields show that compared with ACO, the path length optimization rate of MS-ACO are 3.89%, 4.6% and 2.86%, respectively, the optimization rate of total path angles are 21.94%, 45.06% and 55.94%, respectively, and the optimization rate of node numbers are 61.05%, 74.84% and 75.47%, respectively. MS-ACO can effectively reduce the corner cost and the number of nodes. The results of field experiments show that for each test field, MS-ACO has a significant optimization effect compared with ACO, with an optimization rate of energy consumption per meter of more than 30%, the optimization rate of flight time are 46.67%, 56% and 59.01%, respectively, and the optimization rate of corner angle are 50.76%, 61.78% and 71.1%, respectively. Discussion: The feasibility and effectiveness of the algorithm were further verified. The algorithm proposed in this study can optimize the spraying path according to the position of each fruit tree and the flight characteristics of UAV, effectively reduce the energy consumption of UAV flight, improve the operating efficiency, and provide technical reference for the waypoint planning of plant protection UAV in the orchard scene.

4.
J Obstet Gynaecol Res ; 48(8): 2151-2161, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-35751569

RESUMEN

INTRODUCTION: To investigate the expression of miR-146a in severe preeclampsia (PE) and its effect on trophoblast cell proliferation, invasion and apoptosis, as well as its relationship with SMAD4. MATERIAL AND METHODS: Participants were divided into the severe PE group (n = 30) and the normal group (n = 30). The expression of miR-146a and SMAD4 in placenta tissue was detected by immunohistochemistry, qRT-PCR, and western blot. Trophoblast cell lines HTR-8/SVneo were cultured to detect the expression of miR-146a under the Cobalt chloride (CoCl2 )-simulated hypoxia. The effects of miR-146a transfection on cell proliferation, invasion, apoptosis, and SMAD4 expression were analyzed. RESULTS: Compared with the normal group, miR-146a expression was decreased and the protein and mRNA levels of SMAD4 were increased in placenta tissues of the severe PE group. Our in vitro experiments showed that the expression of miR-146a decreased after CoCl2 treatment. Silencing miR-146a caused increased expression of SMAD4 and decreased expression of VEGF. After transfection with miR-146a inhibitor, compared with the NC group, the invasion and proliferation of HTR-8/Svneo cells were decreased, while the apoptosis was enhanced. CONCLUSION: The expression of miR-146a decreased in severe PE and was negatively correlated with SMAD4 expression. The expression of miR-146a was inhibited under hypoxia, and the low expression of miR-146a affected the proliferation, invasion, and apoptosis of trophoblast cells.


Asunto(s)
MicroARNs , Preeclampsia , Movimiento Celular/genética , Proliferación Celular/genética , Femenino , Humanos , Hipoxia/metabolismo , MicroARNs/metabolismo , Placenta/metabolismo , Preeclampsia/genética , Preeclampsia/metabolismo , Embarazo , Mujeres Embarazadas , Proteína Smad4/genética , Proteína Smad4/metabolismo , Trofoblastos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA